CONTACT US   |  (864) 397-5101

SC pharma company continues expansion in Lexington County

Compliments of the Post and Courier

Nephron Pharmaceuticals’ expansion is progressing as production gets underway on a spate of new business ventures — from at-home COVID-19 test kits to chemotherapy drugs.

Since 2020, the West Columbia drug maker has invested $215 million to build out its campus in Lexington County’s Saxe Gotha Industrial Park. In the past month, the company hired 1,500 new part-time workers as it ramps up production of new product lines, CEO Lou Kennedy said, bringing it to 1,200 full-time employees and 2,500 part-timers.

The hiring spree comes as Nephron produced 30 million doses of reagent for Abbott Laboratories’ at-home COVID-19 test kits last month and assembled about 1 million kits. Kennedy hopes to increase kit production to 2 million per month in January as demand for them has skyrocketed amid new variants of the deadly virus. 

CONTINUE READING FULL STORY HERE…

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.